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Abstract 
Nicotine addiction, related to cigarette smoking, develops as a product of the complex 
interactions between social, environmental and genetic factors. Genes encoding the components 
of the dopaminergic system are thought to be associated with smoking. Literature data showed 
an association, but also a lack of association between variable number of tandem repeats 
(VNTR) polymorphism located in the third exon of dopamine D4 receptor (DRD4) gene and 
smoking. Repetitive sequence of DRD4 VNTR is 48 bp long and maximum 11 tandem copies 
were reported in humans. Presence of alleles with 6 and more repeats (i.e. long alleles) was 
associated with greater tendency to novelty seeking and addictive behaviors than the presence of 
5 and less alleles (short alleles). The aim of this study was to determine the association between 
VNTR in DRD4 gene and present smoking status in ethnically homogenous Caucasian 
population from the Eastern European (Croatian) origin. Genotyping was done in 565 healthy 
subjects, 511 men and 54 women, respectively, who were subdivided into 176 smokers and 389 
nonsmokers. Logistic regression analyses, adjusted for age and sex, revealed the lack of 
significant (p>0.05) effect of the 4/4, 4/7 and 7/7 genotypes, or carriers of the long and short 
allele, or all genotypes of the DRD4 VNTR on smoking status. The results of this study failed to 
confirm the hypothesis that long allele of the DRD4 VNTR is associated with smoking status in 
Caucasian subjects. 
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Introduction 
Nicotine addiction develops under the influence of social, environmental and genetic factors. 
Smoking increases the risk of cancers, cardiovascular and pulmonary diseases, reduces the 
quality of life and causes untimely death [8]. According to World Health Organization (WHO), 
there are more than 1.3 billion regular smokers worldwide and smoking causes around 5 million 
deaths every year. The estimated smoking prevalence in Croatia is 34.1% among men and 26.6% 
among women. In addition, during a one year period around 10 000 people in Croatia die as a 
consequence of smoking-related diseases (The Ministry of Health of the Republic of Croatia). 
Initiation of smoking is highly influenced by social factors, while smoking persistence is affected 
by the genetic factors [15, 31]. Nicotine dependence candidate genes are genes coding the 
components of the serotonergic and dopaminergic systems, nicotine receptors and enzymes 
involved in nicotine metabolism [2, 28]. 
Dopamine is a catecholamine neurotransmitter involved in the reward pathways and 
development of addictive behaviors. Addictive substances activate reward pathways and increase 
dopamine release in the brain [5], while nicotine binds to nicotinic acetylcholine receptors 
(nAChR) in the brain and stimulates dopamine release [19]. There are five subtypes of dopamine 
receptors divided into two classes: D1-like receptors (D1 and D5) and D2-like receptors (D2, D3 
and D4). Dopamine receptor D4 (DRD4 or D4DR) gene is located on chromosome 11 (region 
11p15.5). Location of the DRD4 gene in the telomeric region of the chromosome might be the 
reason of multiple polymorphisms existence inside the gene and 5’ regulatory region [16]. 
Variable number of tandem repeats (VNTR) polymorphism in the third exon of DRD4 gene 
consists of 48 bp long repetitive sequence with 1-11 copies in humans [7, 37]. The most common 
variants are those with 4 (64 %) and 7 repeats (20 %) [22]. The VNTR region codes for amino 
acids in the third cytoplasmic loop of the receptor, a region of G-protein coupled receptors 
thought to have functional importance with respect to G-protein coupling [14]. The influence of 
VNTR on receptor function is still not clear. It is assumed that VNTR can affect dopamine 
binding, connection with second messengers and signal transduction [22]. The effect of DRD4 
receptor on cAMP is two-fold lower in long allele carriers than in short allele carriers [1, 37]. 
Individuals with 7 repeats allele (long allele carriers) have a higher tendency of novelty seeking 
[3, 9], which is often associated with addictive behaviors. There is an association of DRD4 long 
allele (DRD4L) with greater urge for drinking among alcoholics [12], greater heroine uptake 
among heroin addicts [33] and greater urge for food cues among individuals with eating 
disorders [35]. The results showing the association between nicotine addiction and DRD4 VNTR 
are conflicting. No association between DRD4 VNTR polymorphism and smoking [17, 20, 23, 
34, 38], or significant association between DRD4 VNTR and nicotine dependence [6, 11, 18, 24, 
29] was previously reported. 
Given the fact that genetic variations in components of the dopaminergic system might 
alter the risk of smoking [32, 34], and in an effort to elucidate the role of DRD4 VNTR in 
smoking, we performed the current study with the aim of evaluating the association between 
dopamine receptor D4 gene VNTR polymorphism and nicotine addiction in medication-free 
Caucasian healthy subjects of European origin.  
 
Material and methods 
Research subjects 
The study included 511 (159 smokers and 352 nonsmokers) men and 54 (17 smokers and 37 
nonsmokers) women who were unrelated, medication-free Caucasian healthy subjects of 
Croatian origin and were recruited in the period between 2006 and 2010 at the University 
Hospital Centre Zagreb, Zagreb, Croatia. They filled in the questionnaire answering the 
questions about their detail medical history, smoking and drinking habits. Inclusion criteria were: 
no current medication therapy; no previous or current psychiatric disorders other than nicotine 
addiction; no drug or alcohol abuse, no suicidal attempts and no family history of psychiatric 
disorders (determined according to the answers of participants about the mental health status of 
their parents, grandparents, siblings and children). Smokers were classified as subjects smoking 
≥10 cigarettes per day and non-smokers were classified as never-smokers and ex-smokers. There 
were only 9 ex-smokers, categorized into non-smokers, since they quitted smoking more than 10 
years ago. Men were 39.9 ± 12.1 and women were 42.4 ± 13.1 years old. Written informed 
consent was obtained from all participants, after explaining the aims and procedures of the study, 
under procedures approved by the Ethics committee of the Clinical Hospital Centre Zagreb, 
Zagreb, Croatia. All human studies have been carried out with the full cooperation of 
participants, adequate understanding, and have therefore been performed in accordance with the 
ethical standards laid down in the 1964 Declaration of Helsinki. 
Genotyping 
Subjects’ blood samples (8 ml) were drawn using plastic syringes with 2 ml of acid citrate 
dextrose anticoagulant. Genomic DNA was extracted from peripheral blood using the salting out 
method [30]. The 48 bp repeats polymorphism in the third exon of the DRD4 gene was detected 
by polymerase chain reaction (PCR) using Gene Amp PCR system 2700 (Applied Biosystems, 
USA). Primers used were 5'–AGGACCCTCATGGCCTTG–3' and 5'–
GCGACTACGTGGTCTACTCG–3'. PCR was performed in total volume of 15 µl containing 
200 ng of template DNA, 0.8 µM of each primer (Sigma-Aldrich, USA), 0.2 mM of each dNTP 
(dATP, dCTP, dTTP, 50% 7-deaza-GTP, 50% dGTP, Roche, Switzerland), 1 unit of Tfi 
polymerase (Invitrogen, USA), 1X Tfi buffer (Invitrogen, USA), 1X Q-Solution (Qiagen, 
Germany) and 1 µM MgCl2 (Invitrogen, USA). Cycle conditions consisted of an initial 
denaturation at 94°C for 10 min, followed by 35 cycles of denaturation (94°C for 30 s), 
annealing (54°C for 30 s) and extension (72°C for 1 min). Final extension was carried out at 
72°C for 10 min. PCR products were separated by 2% agarose gel electrophoresis, and 
visualized with ultraviolet light after SYBR® Safe (Invitrogen, USA) staining. All laboratory 
procedures were performed blind to subject status. 
 Data analysis 
Subjects were grouped according to their DRD4 genotype in three groups: group A (4/4, 4/7 and 
7/7 genotypes), group B (all genotypes) and group C (carriers of 2-5 repeats (short; s) and 6 or 
more repeats (long; l) DRD4 alleles). Logistic regression analysis was used to elucidate the 
association of the smoking status (smokers vs. non-smokers) as the dependent variable with 
particular DRD4 genotype as independent variable. All analyses were adjusted for age and sex. 
Following the idea that the greatest functional differences are found between 4 and 7 repeats 
alleles, it was assumed that any influence of DRD4 genotype to nicotine addiction would be 
found comparing 4 and 7 repeats carriers. Since heritability of functional effect of DRD4 third 
exon VNTR is still unknown, both dominant and co-dominant effect of 7 repeats allele were 
examined as suggested by Lettre et al. [21]. For dominant effect, 7 repeats allele carriers (7r+) 
were compared with subjects with no 7 repeats allele (7r-). For co-dominant effect, 7 repeates 
allele homozygotes were compared separately with 7 repeates allele heterozygotes and no 7 
repeates allele homozygotes. For group B, only dominant effect was investigated. The results 
were evaluated with SigmaStat 3.1 statistical software (Jandell Scientific Corp. San Raphael, 
California, USA). The Hardy–Weinberg (HWE) analysis was used to test the equilibrium of the 
study group. The level of significance was set to α= 0.05. 
 
Results 
No deviation from the HWE was found in the group of smokers (χ
2
=3.74; df= 1; p=0.053) 
However, deviation from HWE was detected in the group of nonsmokers (χ2= 29.89; df=1; 
p=0.000). All subjects (n=565) were analyzed for the DRD4 genotype and alleles with 2 to 8 
copies of the repeated sequence were found. The most abundant alleles were those with 2 
(11.7%), 4 (71.0%) and 7 repeats (13.0%). Alleles with 3, 5, 6 and 8 repeats had frequencies of 
2.8, 0.8, 0.4 and 0.3%, respectively. Table 1 shows the counts and frequencies of the DRD4 
genotypes in all subjects subdivided according to smoking status into smokers and non-smokers. 
Non-smokers included also a small group (N=9) of ex-smokers, with 6 of them carrying 4/4, 1 
with 4/7, 1 with 4/3 and 1 with 6/8 genotype, respectively. Results of logistic regression 
analyses, adjusted for age and sex, are shown in Table 2. This analysis revealed no significant 
(p>0.05) effect of DRD4 exon 3 VNTR polymorphism on smoking status (Table 2).  
 
Discussion 
The major finding is a lack of association between the DRD4 VNTR gene variants and nicotine 
addiction. Our results concur with some [17, 20, 23, 34, 38], but disagree with other [6, 11, 18, 
24, 29] results. Although there are findings showing an association of long DRD4 gene allele and 
smoking only in men [17], the majority of previous studies did not find sex differences in the 
distribution of long and short alleles [6, 24, 34] and our data are in line with these findings. 
DRD4 VNTR gene variants were in HWE in the group of smokers, while in non-smoker group 
DRD4 VNTR deviated from HWE. The reason for this surprising finding is at present unclear, 
and might be explained by the region-specific sampling, error in selection of subjects sampled at 
the University Hospital Centre where non-smokers predominate, or the presence of population 
substructure. This is a limitation of the study. The association between the DRD4 gene variants 
and smoking is controversial. The inconsistencies might be explained by the ethnic differences, 
since an association of long DRD4 allele with smoking was found in 403 African-Americans but 
not in 72 Caucasian subjects [34]. DRD4 genotype frequencies vary among different ethnical 
groups [36]. It was shown that smokers with depression who are short allele carriers, smoke 
more cigarettes in order to reduce negative feelings caused by depression [20]. Hypothesis about 
the association of long DRD4 gene allele (7 and more repeats) with greater urge for smoking is 
confirmed on 68 smokers from USA [11]. The study carried out on 384 German adolescents 
showed an association of long DRD4 gene allele (7 and more repeats) with smoking for males 
but not for females [17]. The same research group confirmed an association of long DRD4 gene 
allele, long term smoking and lower rates of smoking cessation. Opposite of these findings, study 
including 769 subjects from Australia did not confirm the association of long DRD4 gene allele 
and smoking [23]. Besides that, it has been shown that Caucasian long allele carriers (more than 
5 repeats) can endure the abstinence crisis more easily and exhibit less urge for smoking than 
Caucasian short allele carriers [38]. The influence of VNTR in the third exon of DRD4 gene on 
smoking cessation was also studied in order to develop an individualized nicotine replacement 
therapy [6]. A study with 720 subjects of European ancestry showed that DRD4 gene long allele 
carriers (7 and more repeats) withstood the abstinence crisis for 3 months with more difficulties 
than short allele carriers. However, these results were not confirmed 6 months after quitting 
smoking.  
The influence of VNTR in the third exon of DRD4 gene on the brain of smokers is confirmed 
with neuroimaging findings. Differential activation of brain parts was observed for smokers, long 
and short allele carriers, after exposure to different smoking-related cues [29]. This study was 
performed on 15 smokers from USA. Long allele carriers had a greater activity in brain areas 
involved in response to urge (right frontal gyrus and right insula). It was assumed that in these 
brain areas DRD4 receptors are expressed in high amount [29]. In Caucasian subjects, long allele 
carriers who smoked, needed more time for solving the Stroop test after the exposure to 
smoking-related cues, than smokers which were DRD4 gene short allele carriers [24]. Binding of 
nicotine to nicotinic receptors (nAChR) located on dopaminergic neurons in ventral tegmental 
area (VTA), enhanced dopamine release in nucleus accumbens [19]. Nicotinic receptors are also 
located on GABA-ergic, glutamatergic and cholinergic neurons. GABA-ergic interneurons 
provide inhibitory control over dopaminergic neurons, wheres glutamatergic neurons from 
prefrontal cortex (PFC) and cholinergic neurons from tegmental pedunculopontine nucleus (TPP) 
have stimulatory effects on VTA. After nicotine exposure, inhibitory effects of GABA are 
reduced and positive effects of glutamatergic and cholinergic projections are increased, resulting 
in increased dopamine release from VTA [19, 27]. Smokers, DRD4 short allele carriers, who 
have low resting dopamine tone, had greater smoking-induced dopamine release than individuals 
with other DRD4 genotypes [4, 32]. Brody et al. [4] reported an association between decreased 
craving and increased dopamine concentration with smoking. In DRD4 long allele carriers, the 
ability of dopamine to inhibit cAMP formation is decreased, and these individuals have a greater 
resting dopaminergic tone, and lower smoking-induced dopamine release than DRD4 short allele 
carriers [4]. Therefore, DRD4 long allele carriers are expected to have greater craving for 
nicotine and higher vulnerability to smoking. 
Negative results about the association of DRD4 gene variant and smoking are probably due the 
influence of ethnicity, since there was an association between DRD4 gene long allele and 
smoking in African-Americans, but not in Caucasian subjects [34]. It is assumed that the 
presence of DRD4 long allele does not predispose the development of addictive behavior, 
however long allele can influence the severity of addictive behavior [25]. In addition, DRD4 
VNTR can influence only particular endophenotype (a narrowly defined phenotype closely 
associated with biological mechanism) in smoking behavior. Endophenotype studies should 
prevent inaccurate results in genetic studies [10]. In the case of smoking, candidate for 
endophenotype might be a “cue-elicited craving”. Although clinical importance of craving is 
controversial, previous studies confirmed that craving has an important role in the long-term 
addictions [33]. Namely, studies about the influence of smoking and alcohol cues on individuals 
show a greater urge at individuals with DRD4 gene long allele [11, 12, 26]. In line with this, 
pharmacogenetic study [13] revealed that urge for drinking can be reduced by a DRD4 
antagonist. It was also proposed that DRD4 is a regulator of “cue-elicited craving” and controls 
this endophenotype at nicotine addiction [13].  
Conclusion 
In conclusion, the results of the study did not confirm a significant association between 
DRD4 VNTR alleles and smoking in healthy medication-free Caucasian subjects. Further studies 
should focus on the association between DRD4 alleles and “cue-elicited craving for nicotine”, or 
the influence of DRD4 long allele on the severity of addiction among smokers in a larger sample. 
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Table 1: Dopamine receptor D4 genotype counts and frequencies in healthy subjects subdivided 
according to smoking status 
 
   Smoking status 
DRD4 
genotype 
Counts 
Frequencies 
(%) 
Smoking 
(N=176) 
Non-smoking 
(N=389) 
2/2 31 5.5 8 (4.5) 23 (5.9) 
2/4 64 11.3 17 (9.7) 47 (12.1) 
2/7 1 0.2 0 (0) 1 (0.3) 
2/n 5 0.9 1 (0.6) 4 (1.0) 
4/4 308 54.5 99 (56.3) 209 (53.7) 
4/7 95 16.8 36 (20.5) 59 (15.2) 
4/n 24 4.2 3 (1.7) 21 (5.4) 
7/7 22 3.9 6 (3.4) 16 (4.1) 
7/n 9 1.6 5 (2.8) 4 (1.0) 
n/n 6 1.1 1 (0.6) 5 (1.3) 
              n = 3-, 5-, 6-, 8- repeats allele 
Table 2. Logistic regression analyses predicting smoking status. 
  Group A
a
 Group B
b
 Group C
c
 
  7r- vs. 7r+ 7r- vs. 7r+ s vs. l 
Dominant effect 
OR 0.83 0.71 0.76 
95% CI 0.53-1.31 0.47-1.08 0.50-1.15 
p 0.429 0.113 0.196 
  Group A
a,
*  
  4/4 vs. 7/7 4/7 vs. 7/7  
Co-dominant effect 
OR 1.27 1.67  
95% CI 0.48-3.37 0.59-4.70  
p 0.632 0.333  
a, b
 7 repeats allele as a reference category; 
c
 long allele as a reference category; * 7/7 genotype as 
a reference category. All analyses were adjusted for age and sex. 
